The Middle EAST Infection Control Products Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.2 billion by 2034, registering a CAGR of 8.1%. This growth trajectory is underpinned by several factors, including the increasing prevalence of infectious diseases, rising healthcare expenditures, and heightened awareness regarding infection control practices. The demand for...